Literature DB >> 16471178

Chronic hypoxia accelerates the progression of atherosclerosis in apolipoprotein E-knockout mice.

Daisuke Nakano1, Tetsuya Hayashi, Naoko Tazawa, Chika Yamashita, Sakiko Inamoto, Nobuaki Okuda, Tatsuhiko Mori, Koichi Sohmiya, Yasushi Kitaura, Yoshikatsu Okada, Yasuo Matsumura.   

Abstract

The aim of this study was to investigate the effect of chronic hypoxia on the development and progression of atherosclerosis in apolipoprotein E-knockout (apoE-KO) mice. Male and female apoE-KO mice (6 weeks old) and age- and sex-matched wild-type mice were kept under hypoxic conditions (10.0 +/- 0.5% O2) in a gas chamber or in room air for 3 weeks. Aortic atherosclerotic plaque was not observed in wild-type mice under normoxic or hypoxic conditions. In the apoE-KO mice, however, hypoxia induced proliferation of smooth muscle cells and plaque formation in the aorta, which were not observed under normoxic conditions. Although sexual dimorphism of the response to hypoxia was not observed, these hypoxia-induced atherogenic changes were accompanied by a significant increase of plasma low density lipoprotein (LDL) cholesterol and NADPH-dependent vascular superoxide (O2-) production. Furthermore, matrix metalloproteinase (MMP)-9 was activated in the aorta of apoE-KO mice. In conclusion, chronic hypoxia accelerated the development of atherosclerosis in apoE-KO mice, along with increased O2- production and activated MMP-9 in the aorta.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16471178     DOI: 10.1291/hypres.28.837

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  22 in total

Review 1.  Potential contributions of intimal and plaque hypoxia to atherosclerosis.

Authors:  Guo-Hua Fong
Journal:  Curr Atheroscler Rep       Date:  2015-06       Impact factor: 5.113

2.  Moderate hypoxia potentiates interleukin-1β production in activated human macrophages.

Authors:  Eduardo J Folco; Galina K Sukhova; Thibaut Quillard; Peter Libby
Journal:  Circ Res       Date:  2014-09-02       Impact factor: 17.367

3.  Hypoxemia as a model for high altitude and cardiovascular risk reduction.

Authors:  Friedrich C Luft
Journal:  J Mol Med (Berl)       Date:  2016-03       Impact factor: 4.599

4.  Hypoxia stimulates the proliferation of neonatal rat vascular smooth muscle cells through activation of hypoxia-inducible factor-1α.

Authors:  Guorong Lv; Yanru Li; Zhenhua Wang; Huitong Lin
Journal:  Int J Clin Exp Med       Date:  2015-01-15

5.  Hypoxia in plaque macrophages: a new danger signal for interleukin-1β activation?

Authors:  Ismail Sergin; Trent D Evans; Somashubhra Bhattacharya; Babak Razani
Journal:  Circ Res       Date:  2014-10-24       Impact factor: 17.367

6.  Intermittent hypobaric hypoxia promotes atherosclerotic plaque instability in ApoE-deficient mice.

Authors:  Sihua Jiang; Feipeng Jin; De Li; Xingmei Zhang; Yun Yang; Dachun Yang; Kun Li; Yongjian Yang; Shuangtao Ma
Journal:  High Alt Med Biol       Date:  2013-06       Impact factor: 1.981

7.  Hypoxia stimulates the expression of macrophage migration inhibitory factor in human vascular smooth muscle cells via HIF-1alpha dependent pathway.

Authors:  Hua Fu; Fengming Luo; Li Yang; Wenchao Wu; Xiaojing Liu
Journal:  BMC Cell Biol       Date:  2010-08-20       Impact factor: 4.241

Review 8.  Inflammasomes: a preclinical assessment of targeting in atherosclerosis.

Authors:  Jeremiah Stitham; Astrid Rodriguez-Velez; Xiangyu Zhang; Se-Jin Jeong; Babak Razani
Journal:  Expert Opin Ther Targets       Date:  2020-08-06       Impact factor: 6.902

9.  Intervertebral disc degeneration and ectopic bone formation in apolipoprotein E knockout mice.

Authors:  Dawei Zhang; Li Jin; Davis L Reames; Francis H Shen; Adam L Shimer; Xudong Li
Journal:  J Orthop Res       Date:  2012-08-22       Impact factor: 3.494

10.  Regulation of oxidative stress and cardioprotection in diabetes mellitus.

Authors:  Tetsuya Hayashi; Tatsuhiko Mori; Chika Yamashita; Masatoshi Miyamura
Journal:  Curr Cardiol Rev       Date:  2008-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.